An Experimental Study of Low Dose Oxaliplatin Inhibiting Tumor Angiogenesis in Vivo

孙永臣,钱晓萍,刘宝瑞,胡静,胡文静,禹立霞

DOI: https://doi.org/10.3969/j.issn.1672-2353.2009.03.009

2009-01-01

Abstract:Objective To observe inhibition effect of low dose oxaliplatin(L-OHP) on the growth of tumor transplanted froma mouse and its effect on the expression of vascular endothecial growth factor(VEGF) and microvessel density(MVD).Methods A mouse tumor model was set up by implanting H22 mouse liver cancer cells under the skins of mice.Forty experimental mice were divided randomly into four groups,including control 5 %glucose injection negative control group,cyclophosphamide(CTX) 20 mg/kg positive control group,Oxaliplatin 0.75 mg/kg group and Oxaliplatin 1.5 mg/kg group.The four groups were injected intraperitoneally with the same amount of injection,once a day for ten days.On Day 11 the mice were killed and the tumors were taken out and the tumor-weight-inhibition ratios were calculated.Tumors were examined by using immunohistochemical staining to study the expression of VEGF and MVD.Results The tumor-weight in the experimental oxaliplatin 1.5 mg/kg group was significantly lower than that of the negative control group(P0.01),and so was the expression of VEGF and MVD(P0.01).Conclusion Low dose oxaliplatin has significant inhibitory effect on the growth of the tumors and the expression of the VEGF and MVD in H22 liver cancer tumor-bearing mice;Low dose oxaliplatin maybe has inhibitory effect on angiogenesis of tumor tissue in vivo.